JA310
Product Specifications
UNSPSC Description
JA310 is a highly selective MST3 kinase inhibitor. JA310 has high cellular potency against MST3 with an EC50 value of 106 nM[1].
Target Antigen
Hippo (MST)
Type
Reference compound
Related Pathways
Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ja310.html
Solubility
DMSO : 2 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
O=C1C2=CC(NC3=C4C(C=CC=C4)=NC(NCCCCCN1)=N3)=NN2
Molecular Weight
337.38
References & Citations
[1]Amrhein JA, et al. Synthesis of Pyrazole-Based Macrocycles Leads to a Highly Selective Inhibitor for MST3. J Med Chem. 2023 Dec 21.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-160211/JA310-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-160211/JA310-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
3022928-90-8
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CD45R (CD45 Antigen, B220, GP180, Leukocyte Common Antigen, LCA, L-CA, LY5, LY-5, Protein Tyrosine Phosphatase Receptor Type C Polypeptide, PTPRC, T200, T200 Glycoprotein) (AP)
CD45R (CD45 Antigen, B220, GP180, Leukocyte Common Antigen, LCA, L-CA, LY5, LY-5, Protein Tyrosine Phosphatase Receptor Type C Polypeptide, PTPRC, T200, T200 Glycoprotein) (AP)
